Connect
← Return to Ibrance and Letrozole: Newly Diagnosed Treatment
Discussion
Ibrance and Letrozole: Newly Diagnosed Treatment
Breast Cancer | Last Active: Jan 22, 2023 | Replies (104)Comment receiving replies
Chris, there are a lot of posts about the gene testing, the OncotypeDX being the most frequent one for estrogen-positive breast cancer. And there are misconceptions about it that are still out there, including among doctors according to an article I cited, with URL, on a thread. If a moderator can move those to a separate thread, the information would be in one place for anyone wanting to understand why the test is used and how to interpret the results when it is.
Replies to "Chris, there are a lot of posts about the gene testing, the OncotypeDX being the most..."
Connect
I understand that there are many tests. My point was that the conversation about these tests seems to be repeated in many threads where it really isn’t relevant to the topic of the thread. Maybe you could start a new thread about the available genetic tests, and keep that conversation going there. There are other folks who are taking part in those conversations so it should be relatively lively, as well as making space in other threads for on topic conversation.